Updated on 11 Nov 2026, 09:59 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,899.10 | -0.31 | 4,55,646.97 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 11,377.75 | -1.66 | 3,02,043.51 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,769.80 | -0.11 | 1,81,421.37 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,413.10 | 0.50 | 1,14,158.47 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,202.45 | -0.87 | 1,19,944.85 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-07-21 | Quarterly Results |
| 2026-05-19 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
Anthem BioSciences is trading at 966.30 as on Wed Nov 11 2026 04:19:13. This is 0.77% upper as compared to its previous closing price of 958.90.
The market capitalization of Anthem BioSciences is 54453.72 Cr as on Wed Nov 11 2026 04:19:13.
The average broker rating on Anthem BioSciences is Buy. The breakup of analyst rating is given below -
The 52 wk high for Anthem BioSciences is 989.15 whereas the 52 wk low is 579.45
Anthem BioSciences can be analyzed on the following key metrics -
Anthem BioSciences reported a net profit of 591.79 Cr in 2026.
The Mutual Fund Shareholding was 9.25% at the end of 30 Sep 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.